Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 10, Pages 5515
Publisher
MDPI AG
Online
2022-05-15
DOI
10.3390/ijms23105515
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients
- (2022) Ravi Ramalingam et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers
- (2022) Giuliana Beneduce et al. Cancers
- Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis
- (2022) Franco Locatelli et al. Blood Advances
- Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia
- (2021) Franco Locatelli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers
- (2021) Raffaele Di Francia et al. Cancers
- Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
- (2021) Barthelemy Diouf et al. CTS-Clinical and Translational Science
- Acute lymphoblastic leukemia
- (2021) John Han‐Chih Chang et al. PEDIATRIC BLOOD & CANCER
- Pharmacogenetic evaluation of 6-mercaptopurine-mediated toxicity in pediatric acute lymphoblastic leukemia patients from a South Indian population
- (2021) Ravi Ramalingam et al. PHARMACOGENOMICS
- Circumventing the side effects of L-asparaginase
- (2021) Marcela Helena Gambim Fonseca et al. BIOMEDICINE & PHARMACOTHERAPY
- Vincristine induced neurotoxicity in children who underwent chemotherapy for acute lymphoblastic leukemia and Wilms tumor
- (2021) Muhammad Kamran Adil et al. Pakistan Journal of Medical Sciences
- Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor
- (2021) Qing-Yan Yang et al. Frontiers in Pharmacology
- How I Treat: Selecting CD19 Targeted Immunotherapies in Adult Patients with Advanced Acute Lymphoblastic Leukemia
- (2020) Ibrahim Aldoss et al. BLOOD
- CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
- (2020) Nirali N. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group
- (2020) Tadashi Kumamoto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children’s Oncology Group AALL0434
- (2020) Robert J. Hayashi et al. JOURNAL OF CLINICAL ONCOLOGY
- Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden
- (2020) Daniel J. DeAngelo et al. Blood Cancer Journal
- Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia
- (2020) Dimitri Maamari et al. Pharmacogenomics & Personalized Medicine
- Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
- (2020) Kimberly P. Dunsmore et al. JOURNAL OF CLINICAL ONCOLOGY
- Precision medicine in acute lymphoblastic leukemia
- (2020) Ching-Hon Pui Frontiers of Medicine
- Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL
- (2020) Vipul S Sheth et al. BONE MARROW TRANSPLANTATION
- Blinatumomab in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia
- (2020) Manon Queudeville et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL
- (2019) George Hucks et al. Blood Cancer Journal
- CAR T-cell associated neurotoxicity: Mechanisms, clinicopathologic correlates, and future directions
- (2019) Bradley D Hunter et al. JNCI-Journal of the National Cancer Institute
- Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study
- (2019) Hagop M. Kantarjian et al. CANCER
- A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora
- (2019) Lisandra Herrera Belén et al. BIOLOGICALS
- Branched-Chain Amino Acids and Seizures: A Systematic Review of the Literature
- (2019) Shaun E. Gruenbaum et al. CNS DRUGS
- Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
- (2019) Chelsea Kotch et al. Expert Review of Clinical Immunology
- Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric–modified Total Neuropathy Score
- (2019) S. M. Schouten et al. SUPPORTIVE CARE IN CANCER
- Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16
- (2019) Sima Jeha et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia
- (2018) Natalia C. Millan et al. LEUKEMIA RESEARCH
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)
- (2018) Bianca D. Santomasso et al. Cancer Discovery
- Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors
- (2018) Anthony S. Stein et al. ANNALS OF HEMATOLOGY
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Toward the development of true “off-the-shelf” synthetic T-cell immunotherapy
- (2018) Shoichi Iriguchi et al. CANCER SCIENCE
- Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies
- (2018) Juliane Gust et al. CNS DRUGS
- Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia
- (2017) Chee Geap Tay et al. PEDIATRIC BLOOD & CANCER
- Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia
- (2017) Burcu Yazıcıoğlu et al. Turkish Journal of Hematology
- An Inherited Genetic Variant inCEP72Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia
- (2016) W Stock et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia
- (2016) N.J. Morley et al. Expert Review of Anticancer Therapy
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence ofADORA2Agene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies
- (2016) Shin-ichi Tsujimoto et al. PEDIATRIC BLOOD & CANCER
- The double-edged sword: Neurotoxicity of chemotherapy
- (2015) Rajiv S. Magge et al. BLOOD REVIEWS
- FDA Approval: Blinatumomab
- (2015) D. Przepiorka et al. CLINICAL CANCER RESEARCH
- Therapeuticl-asparaginase: upstream, downstream and beyond
- (2015) André Moreni Lopes et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
- (2015) Barthelemy Diouf et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia
- (2015) Ellen M. Lavoie Smith et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
- (2015) Nobuko Hijiya et al. LEUKEMIA & LYMPHOMA
- Acute Lymphoblastic Leukemia in Children
- (2015) Stephen P. Hunger et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia
- (2015) Ajay Abraham et al. PHARMACOGENOMICS
- Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol
- (2015) R Franca et al. PHARMACOGENOMICS JOURNAL
- Association of ADORA1 rs2228079 and ADORA2A rs5751876 Polymorphisms with Gilles de la Tourette Syndrome in the Polish Population
- (2015) Piotr Janik et al. PLoS One
- A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
- (2014) Wing H. Tong et al. BLOOD
- Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia
- (2014) Deepa Bhojwani et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of a microRNA binding site polymorphism in SLC19A1 on methotrexate concentrations in Chinese children with acute lymphoblastic leukemia
- (2014) Shu-mei Wang et al. MEDICAL ONCOLOGY
- Vincristine-induced Neuropathy in Childhood ALL (Acute Lymphoblastic Leukemia) Survivors
- (2013) Puneet Jain et al. JOURNAL OF CHILD NEUROLOGY
- Blinatumomab: A historical perspective
- (2012) Dirk Nagorsen et al. PHARMACOLOGY & THERAPEUTICS
- The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols
- (2011) Rachael F. Grace et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence
- (2011) David Balayssac et al. Expert Opinion On Drug Safety
- Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis
- (2010) Jose Manuel Vagace et al. AMERICAN JOURNAL OF HEMATOLOGY
- Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypersensitivity
- (2010) S-H Chen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic factors influencing cytarabine therapy
- (2009) Jatinder K Lamba PHARMACOGENOMICS
- Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity
- (2008) C. M. Hartford et al. BLOOD
- FDA Drug Approval Summary: Nelarabine (Arranon(R)) for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma
- (2008) M. H. Cohen et al. ONCOLOGIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started